CHICAGO--(BUSINESS WIRE)--Monroe Capital LLC today announced the funding of a $46.5 million unitranche credit facility to support the recapitalization of Conisus, LLC by private equity sponsor, Webster Capital.
Based in Atlanta, GA, Conisus, LLC offers innovative, scientific-oriented promotional marketing and education solutions to a diverse group of biopharmaceutical companies to assist in the promotion and education of oncology drugs and therapies. The company is led by a seasoned management team with deep experience in oncology that spans medical education, global marketing, sales and clinical practice.
About Monroe Capital
Monroe Capital LLC is a leading provider of senior and junior debt and equity co-investments to middle-market companies in the U.S. and Canada. Investment types include unitranche financings, cash flow and enterprise value based loans, acquisition facilities, mezzanine debt, second lien or last-out loans and equity co-investments. Monroe Capital prides itself on its flexible investment approach and its ability to close and fund transactions quickly. Monroe is committed to being a value-added and user-friendly partner to owners, senior management and private equity sponsors. To learn more about Monroe Capital LLC, visit www.monroecap.com
About Webster Capital
Founded in 2003, Webster Capital is a private equity partnership with over $200 million in capital under management which invests in healthcare services, branded consumer and business to business companies. Webster focuses on companies with EBITDA of between $3 million to $15 million and transaction values of less than $100 million. Webster Capital provides equity financing, expertise and a broad contact network for management buyouts and growth capital. For additional information on Webster Capital please visit www.webstercapital.com.